CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 30, 2014--
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of
cancer metabolism and inborn errors of metabolism, today announced that
it will host a conference call and live webcast on Thursday, May 8,
2014, at 8:30 a.m. EDT to report its first quarter 2014 financial
results and discuss recent business activities.
The live webcast can be accessed under "Events & Presentations" in the
Investors and Media section of the company's website at www.agios.com.
The conference call can be accessed by dialing 1-877-377-7098 (domestic)
or 1-631-291-4547 (international) and refer to conference ID 32998186.
The webcast will be archived and available for replay on the company's
website beginning approximately two hours after the event.
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals is focused on discovering and developing novel
drugs to treat cancer and inborn errors of metabolism, or IEMs, which
are rare genetic metabolic diseases, through scientific leadership in
the field of cellular metabolism. In addition to an active research and
discovery pipeline across both therapeutic areas, Agios has multiple
first-in-class lead product candidates in cancer metabolism and IEMs in
clinical and/or preclinical development. All Agios programs focus on
genetically identified patient populations, leveraging our knowledge of
metabolism, biology and genomics. For more information, please visit our
website at www.agios.com.
Source: Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals
Lora Pike, Senior Director, Investor
Relations and Public Relations
617-649-8608, investors@agios.com
